Frekamin

Dependable Option in Crisis

  • FrekaminTM I.V. is a tetracycline antibiotic currently approved by the US Food and Drug Administration for the treatment of minocycline-susceptible Acinetobacter species infections. Minocycline has significant in vitro activity both against S. aureus and coagulase-negative staphylococci, including community as well as nosocomial MRSA isolates. Minocycline has the potential to become an important part of the armamentarium against emerging infections such as MRSA and A. baumannii.